Clinical trial

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

NCT07072728

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhasePHASE2

Study timeline

Study start (actual)2025-10-01Date precision: day

Registry last updated2026-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adjustment Disorderunresolved

Adjustment Disorder With Anxious Moodunresolved

Cancerunresolved

Cancer Cachexiaunresolved

Cancer of Endometriumunresolved

Cancer of Kidneyunresolved

Cancer of Prostateunresolved

Cancer of the Breastunresolved

Cancer of Stomachunresolved

Cancer Melanoma Skinunresolved

Cancer Pancreasunresolved

Interventions

Psilocybin therapyDRUG

Sponsors & collaborators

Psyence Australia Pty Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07072728 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.